Gut permeability to lactulose and mannitol differs in treated Crohn's disease and celiac disease patients and healthy subjects

Brazilian Journal of Medical and Biological Research

Volumn 41, Issue 12, 2008, Pages 1105-1109

  Vilela, E G ^a,b   Torres, H O G ^a   Ferrari, M L A ^a   Lima, A S ^a   Cunha, A S ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b NONE   (Brazil)

Author keywords

Celiac disease; Crohn's disease; Intestinal permeability; Lactulose; Mannitol

Indexed keywords

AZATHIOPRINE; CARBOHYDRATE DERIVATIVE; LACTULOSE; MANNITOL; MESALAZINE; METRONIDAZOLE; PREDNISONE; THALIDOMIDE;

ADULT; AGED; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; CROHN DISEASE; DRUG DOSE REDUCTION; DRUG EXCRETION; DRUG URINE LEVEL; FEMALE; GLUTEN FREE DIET; HUMAN; INTESTINE MUCOSA PERMEABILITY; MAJOR CLINICAL STUDY; MALE; PERMEABILITY BARRIER; REMISSION; URINARY EXCRETION;

EID: 62749111325     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2008001200010     Document Type: Article

References (29)

1. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995; 108: 1566-1581.
2. Menzies IS. Absorption of intact oligosaccharide in health and disease. Biochem Soc Trans 1974; 2: 1042-1047.
3. DeMeo MT, Mutlu EA, Keshavarzian A, Tobin MC. Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol 2002; 34: 385-396.
4. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439-444.
5. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6: 8-15.
6. Garcia Vilela E, De Lourdes De Abreu Ferrari M, Oswaldo Da Gama TH, Guerra Pinto A, Carolina Carneiro Aguirre A, Paiva Martins F, et al. Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission. Scand J Gastroenterol 2008; 43: 842-848.
7. Travis S, Menzies I. Intestinal permeability: functional assessment and significance. Clin Sci 1992; 82: 471-488.
8. Vogelsang H, Schwarzenhofer M, Oberhuber G. Changes in gastrointestinal permeability in celiac disease. Dig Dis 1998; 16: 333-336.
9. Perry I, Iqbal T, Cooper B. Intestinal permeability in coeliac disease. Lancet 2001; 358: 1729-1730.
10. Bjarnason I, Peters TJ, Veall N. A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labelled EDTA absorption test. Lancet 1983; 1: 323-325.
11. Menzies IS, Laker MF, Pounder R, Bull J, Heyer S, Wheeler PG, et al. Abnormal intestinal permeability to sugars in villous atrophy. Lancet 1979; 2: 1107-1109.
12. Hollander D. The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease. Scand J Gastroenterol 1992; 27: 721-726.
13. Nash S, Stafford J, Madara JL. The selective and superoxide-independent disruption of intestinal epithelial tight junctions during leukocyte transmigration. Lab Invest 1988; 59: 531-537.
14. Brown SJ, Mayer L. The immune response in inflammatory bowel disease. Am J Gastroenterol 2007; 102: 2058-2069.
15. Hollander D. Crohn's disease, TNF-alpha, and the leaky gut. The chicken or the egg? Am J Gastroenterol 2002; 97: 1867-1868.
16. van Elburg RM, Uil JJ, Mulder CJ, Heymans HS. Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease. Gut 1993; 34: 354-357.
17. Teahon K, Somasundaram S, Smith T, Menzies I, Bjarnason I. Assessing the site of increased intestinal permeability in coeliac and inflammatory bowel disease. Gut 1996; 38: 864-869.
18. Secondulfo M, de Magistris L, Fiandra R, Caserta L, Belletta M, Tartaglione MT, et al. Intestinal permeability in Crohn's disease patients and their first degree relatives. Dig Liver Dis 2001; 33: 680-685.
19. Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 2000; 355: 1518-1519.
20. Uil JJ, van Elburg RM, van Overbeek FM, Meyer JW, Mulder CJ, Heymans HS. Follow-up of treated coeliac patients: sugar absorption test and intestinal biopsies compared. Eur J Gastroenterol Hepatol 1996; 8: 219-223.
21. Duerksen DR, Wilhelm-Boyles C, Parry DM. Intestinal permeability in long-term follow-up of patients with celiac disease on a gluten-free diet. Dig Dis Sci 2005; 50: 785-790.
22. Vilela EG, de Abreu Ferrari ML, de Gama Torres HO, Martins FP, Goulart EM, Lima AS, et al. Intestinal permeability and antigliadin antibody test for monitoring adult patients with celiac disease. Dig Dis Sci 2007; 52: 1304-1309.
23. Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut 2006; 55: 1512-1520.
24. Johnston SD, Smye M, Watson RG. Intestinal permeability and morphometric recovery in coeliac disease. Lancet 2001; 358: 259-260.
25. Bjarnason I, Peters TJ. In vitro determination of small intestinal permeability: demonstration of a persistent defect in patients with coeliac disease. Gut 1984; 25: 145-150.
26. Wyatt J, Vogelsang H, Hubl W, Waldhoer T, Lochs H. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 1993; 341: 1437-1439.
27. D'Inca R, Di Leo V, Corrao G, Martines D, D'Odorico A, Mestriner C, et al. Intestinal permeability test as a predictor of clinical course in Crohn's disease. Am J Gastroenterol 1999; 94: 2956-2960.
28. Meddings JB. Review article: Intestinal permeability in Crohn's disease. Aliment Pharmacol Ther 1997; 11 (Suppl 3): 47-53.
29. Li Q, Zhang Q, Wang M, Zhao S, Ma J, Luo N, et al. Interferon-gamma and tumor necrosis factor-alpha disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction. Clin Immunol 2008; 126: 67-80.